Carlsmed, Inc. 2019 Stock Incentive Plan Performance-Vesting Restricted Stock Unit Award Agreement (Mike Cordonnier)
This agreement between Carlsmed, Inc. and Mike Cordonnier grants him restricted stock units (RSUs) under the company's 2019 Stock Incentive Plan. The RSUs will vest based on performance criteria detailed in an attached exhibit, and must vest within four years from the grant date. Shares will be issued upon vesting, subject to tax withholding. The agreement also includes provisions regarding stockholder agreements, transfer restrictions, and lock-up periods related to public offerings. If the vesting conditions are not met by the expiration date, the RSUs will be forfeited.
Exhibit 10.5
Privileged and Confidential
CARLSMED, INC.
2019 Stock INCENTIVE PLAN
Performance-vesting Restricted Stock Unit AWARD AGREEMENT
You (the “Grantee”) have been granted an award of Restricted Stock Units (the “RSUs”), subject to the terms and conditions of this Performance-Vesting Restricted Stock Unit Award Agreement (this “Agreement”), the Carlsmed, Inc. 2019 Stock Incentive Plan, as may be amended, modified or restated from time to time (the “Plan”). Unless otherwise defined in this Agreement, the terms defined in the Plan shall have the same defined meanings in this Agreement. In the event of a conflict between this Agreement and the Plan, the provisions of the Plan shall control.
Grantee’s Name | Mike Cordonnier |
Grantee’s Address | [***] |
Grantee’s Email Address | [***] |
Grant Date | March 5, 2025 |
Total Number of Shares Subject to the RSU | 627,630 |
Vesting Schedule | As set forth in Exhibit A. |
Expiration Date | The fourth anniversary of the Grant Date. |
2
3
4
THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”) OR ANY STATE SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER THE ACT OR, IN THE OPINION OF COUNSEL SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS IN COMPLIANCE THEREWITH.
THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER, A RIGHT OF FIRST REFUSAL HELD BY THE ISSUER OR ITS ASSIGNEE(S) AS SET FORTH IN THE PERFORMANCE-VESTING RESTRICTED STOCK UNIT AWARD AGREEMENT, ANY STOCKHOLDER’S AGREEMENT OR ANY OTHER AGREEMENT BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THESE SHARES, A COPY OF WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF THE ISSUER. SUCH TRANSFER RESTRICTIONS AND RIGHT OF FIRST REFUSAL ARE BINDING ON TRANSFEREES OF THESE SHARES.
[SIGNATURE PAGE FOLLOWS]
5
IN WITNESS WHEREOF, the Company and the Grantee have executed this Agreement and agree that the RSUs are to be governed by the terms and conditions of this Agreement and the Plan.
Carlsmed, Inc. | |
an Delaware corporation | |
By: | /s/ Niall Casey |
Name: | Niall Casey |
Title: | Secretary |
By the Grantee’s acceptance of this Agreement either electronically through the electronic acceptance procedure established by the Company or through a written acceptance delivered to the Company in a form satisfactory to the Company, the Grantee acknowledges receipt of a copy of the Plan and this Agreement and familiarity with the terms and conditions of the RSUs, and accepts the RSUs subject to all of such terms and conditions. The Grantee has reviewed the Plan and this Agreement in their entirety and has had an opportunity to obtain the advice of counsel prior to executing this Agreement. The Grantee further agrees to notify the Company upon any change in the residence address indicated in this Agreement.
GRANTEE | |
| |
| |
By: | /s/ Mike Cordonnier |
Name: | Mike Cordonnier |
6
Exhibit A
Vesting Schedule
Subject to the Grantee’s Continuous Service with the Company as its Chief Executive Officer and other limitations set forth in the Plan and this Agreement, the RSUs will be eligible to vest in accordance with this Exhibit A.
RSU Vesting Table | |
Incremental Number of RSUs Vested | Target Price* |
313,815 (50%) | $7.70 |
313,815 (50%) | $9.62 |
* The Target Price shall be adjusted, as appropriate, in accordance with Section 10 of the Plan.
In connection with a Corporate Transaction, if the Company’s Series C Preferred Stock (in the case of a Private Company Transaction) or the Shares (in the case of a Public Company Transaction) are entitled to receive any contingent or deferred amounts, including payments subject to earnouts, post-closing purchase price adjustments, escrows, offset rights, holdback terms and similar conditions, the determination of the Fair Market Value and whether any of the RSUs shall vest in connection with such Corporate Transaction shall be made by the Administrator in its sole discretion. The Administrator may determine that RSUs shall vest only at such time as the Company’s Series C Preferred Stock or Shares, as applicable, receive consideration in a sufficient amount to equal or exceed the applicable Target Price(s), in which case the vesting date shall be such date as determined by the Administrator; provided, however, that any such determinations by the Administrator shall be in a manner that complies with (or ensures the RSUs remain exempt from) Code Section 409A.
For the avoidance of doubt, if either (x) the Target Price is not achieved prior to the Expiration Date or (y) except as set forth above with respect to Double-Trigger Acceleration, the Grantee’s employment as the Company’s Chief Executive Officer terminates for any reason (including, for the avoidance of doubt, if the Grantee’s employment continues but in a role other than Chief Executive Officer), then any unvested RSUs granted hereunder shall terminate immediately without consideration.
2